Single-center prospective experience with Optilume® drug-coated balloon for recurrent urethral strictures: preliminary functional and safety outcomes
Optilume<sup>®</sup> DCB treatment demonstrated significant improvements in urinary flow and symptoms with a low recurrence and complication rate at 6 months. It may serve as a minimally invasive alternative for patients unsuitable or unwilling to undergo urethroplasty. Further prospective evaluation is warranted, including its potential role in bladder neck sclerosis and benign prostatic obstruction.
Authors
- Francesco Pio Bizzarri (ORCID: https://orcid.org/0000-0003-2119-9023)
- Eros Scarciglia (ORCID: https://orcid.org/0000-0003-1087-1064)
- Nazario Foschi (ORCID: https://orcid.org/0000-0003-0464-0788)
- Mauro Ragonese (ORCID: https://orcid.org/0000-0002-1919-8729)
- Bernardo Rocco (ORCID: https://orcid.org/0000-0002-9135-0035)
- Mariachiara Sighinolfi
- F. Fantasia
- Antonio Silvestri
- Giovanni Battista Filomena (ORCID: https://orcid.org/0009-0005-8884-6573)
- Pierluigi Russo (ORCID: https://orcid.org/0000-0002-7789-9486)
- Antonio Cretì (ORCID: https://orcid.org/0009-0000-4430-3124)
- V. Cavarra
- Francesco Pinto (ORCID: https://orcid.org/0000-0003-1937-9957)
Institutions
- CTO Hospital (IT)
- Agostino Gemelli University Polyclinic (IT)
- Health & Life (Taiwan) (TW)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1007/s11255-025-04922-3
- Citations
- 1
- Primary Topic
- Urological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- Università Cattolica del Sacro Cuore